Trial Profile
A phase I study of CTI-091 for the treatment of arthritis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2015
Price :
$35
*
At a glance
- Drugs CTI 091 (Primary)
- Indications Arthritis
- Focus Adverse reactions
- 05 Feb 2015 New trial record